Dr. Reddy's Laboratories Ltd. has launched Metaxalone Tablets, USP 800 mg, a therapeutic equivalent generic version of Skelaxin (metaxalone) tablets, approved by US FDA. The Skelaxin brand and generic had US sales of approximately USD 139 million moving annual total (MAT) for the most 12 twelve months ending in July 2017 according to IMS Health. Dr. Reddy's Metaxalone Tablets, USP 800 mg are available in the bottle count size of 100. Skelaxin is a trademark of King Pharmaceuticals Research and Development, Inc.


10 Diagnostic Imaging Trends for 2018

Best of 2017 Medical

 

Digital version